设为首页 加入收藏

TOP

PERSERIS (risperidone) for extended-release injectable suspension,(二十九)
2018-11-25 03:36:51 来源: 作者: 【 】 浏览:18119次 评论:0
20 mg Injectable Suspension Label
NDC 12496-0120-2
once-monthly
PERSERIS™
(risperidone)
for extended-release
injectable suspension
120 mg
For abdominal subcutaneous
injection only.
Please read complete
instructions prior to use.
Please see accompanying
Full Prescribing Information.
Rx only
Sterile
Single-dose only
 Principal Display Panel - Perseris Kit 120 mg Injectable Suspension Label
CLOSE
PRINCIPAL DISPLAY PANEL
Principal Display Panel - Perseris Kit 120 mg Delivery System Label
NDC 12496-0776-2
Delivery System
for PERSERIS™ 120 mg
For abdominal subcutaneous
injection only.
Please read complete
instructions prior to use.
Please see accompanying
Full Prescribing Information.
Rx only
Sterile
Single-dose only
 Principal Display Panel - Perseris Kit 120 mg Delivery System Label
CLOSE
PRINCIPAL DISPLAY PANEL
Principal Display Panel - Perseris Kit 120 mg Syringe Label
NDC 12496-0120-5
Rx only
Sterile
PERSERIS™
(risperidone)
For abdominal
subcutaneous
injection only.
120 mg
Powder
Syringe
 Principal Display Panel - Perseris Kit 120 mg Syringe Label
CLOSE
PRINCIPAL DISPLAY PANEL
Principal Display Panel - Perseris Kit 120 mg Delivery System Label
NDC 12496-0776-5
Rx only
Sterile
Delivery System
for PERSERIS™ 120 mg
For abdominal
subcutaneous
injection only.
Liquid
Syringe
 Principal Display Panel - Perseris Kit 120 mg Delivery System Label
CLOSE
INGREDIENTS AND APPEARANCE
PERSERIS
risperidone kit
PRODUCT INFORMATION
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:12496-0090
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:12496-0090-1 1 in 1 CARTON; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 11/19/2018 
QUANTITY OF PARTS
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 1.2 mL
Part 2 1 SYRINGE 1 mL
Part 1 of 2
PERSERIS
risperidone powder
PRODUCT INFORMATION
Route of Administration SUBCUTANEOUS
ACTIVE INGREDIENT/ACTIVE MOIETY
Ingredient Name Basis of Strength Strength
Risperidone (UNII: L6UH7ZF8HC) (Risperidone - UNII:L6UH7ZF8HC) Risperidone 90 mg  in 0.6 mL
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1  1 in 1 POUCH  
1  1.2 mL in 1 SYRINGE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA210655 11/19/2018 
Part 2 of 2
DELIVERY SYSTEM
poly(dl-lactic-co-glycolic acid), (50:50; 46000 mw), methylpyrrolidone liquid
PRODUCT INFORMATION
Item Code (Source) NDC:12496-0589
Route of Administration SUBCUTANEOUS
INACTIVE INGREDIENTS
Ingredient Name Strength
Poly(DL-lactic-co-glycolic acid), (50:50; 46000 MW) (UNII: LQ35R50VR1) 
Methylpyrrolidone (UNII: JR9CE63FPM)&nb
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 26 27 28 29 30 31 下一页 尾页 29/31/31
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Vitrakvi(larotrectinib)Capsules.. 下一篇DAURISMOTM(glasdegib)tablets, f..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位